We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+10.11%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$47.1B
AUM Growth
+$2.61B
(+5.9%)
Cap. Flow
-$501M
Cap. Flow
% of AUM
-1.06%
Top 10 Holdings %
Top 10 Hldgs %
14.43%
Holding
3,576
New
705
Increased
706
Reduced
825
Closed
988
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walmart Inc
WMT
|
+$417M |
| 2 |
Meta Platforms (Facebook)
META
|
+$383M |
| 3 |
Amazon
AMZN
|
+$308M |
| 4 |
Microsoft
MSFT
|
+$293M |
| 5 |
GE Aerospace
GE
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cigna
CI
|
+$312M |
| 2 |
Bank of America
BAC
|
+$292M |
| 3 |
ExxonMobil
XOM
|
+$274M |
| 4 |
lululemon athletica
LULU
|
+$238M |
| 5 |
Qualcomm
QCOM
|
+$228M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.05% |
| 2 | Technology | 14.35% |
| 3 | Consumer Discretionary | 13.97% |
| 4 | Financials | 9.9% |
| 5 | Industrials | 6.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OPTN
2501
DELISTED
OptiNose
OPTN
| $57.6K | ﹤0.01% |
1,989
| – | – |
|
|
CEPU
2502
Central Puerto
CEPU
$2.32B
| $57.3K | ﹤0.01% |
10,591
-50,032
| -83% | -$298K |
|
|
SONDW
2503
CALL
DELISTED
Sonder Holdings Inc Warrants
SONDW
| $57K | ﹤0.01% |
75,000
-9,567
| -11% | -$1.18K |
|
|
AEVA
2504
Aeva Technologies
AEVA
$1.13B
| $55.2K | ﹤0.01% |
9,284
| – | – |
|
2505
CALL
P3 Health Partners Inc Warrant
PIIIW
$133K
| $54.4K | ﹤0.01% |
51,353
-23,647
| -32% | -$2.79K |
|
|
BFX
2506
DELISTED
BowFlex Inc.
BFX
| $54.4K | ﹤0.01% |
+40,567
| New | +$67.1K |
|
|
NAGE
2507
Niagen Bioscience
NAGE
$264M
| $52.9K | ﹤0.01% |
34,600
-47,492
| -58% | -$84.5K |
|
2508
Focus Universal
FCUV
$1.32M
| $52.6K | ﹤0.01% |
+53
| New | +$76.6K |
|
|
WIMI
2509
WiMi Hologram Cloud
WIMI
$22.2M
| $52.4K | ﹤0.01% |
+4,855
| New | +$59.1K |
|
|
LEV
2510
DELISTED
The Lion Electric Company
LEV
| $51.7K | ﹤0.01% |
27,782
| – | – |
|
2511
AvePoint
AVPT
$2.72B
| $50.3K | ﹤0.01% |
+12,217
| New | +$55.1K |
|
|
DRRX
2512
DELISTED
DURECT Corp
DRRX
| $50.2K | ﹤0.01% |
+11,073
| New | +$60.1K |
|
2513
CALL
Occidental Petroleum
OXY
$55.6B
| $49.9K | ﹤0.01% |
800
| – | – |
|
2514
Itaú Unibanco
ITUB
$93B
| $49.2K | ﹤0.01% |
+11,443
| New | +$48.5K |
|
|
CURO
2515
DELISTED
CURO Group Holdings Corp.
CURO
| $48.8K | ﹤0.01% |
28,180
-14,994
| -35% | -$48.7K |
|
2516
Nuvation Bio
NUVB
$2.33B
| $48.3K | ﹤0.01% |
29,111
| – | – |
|
2517
Caesarstone
CSTE
$71.6M
| $48.1K | ﹤0.01% |
11,640
-50,820
| -81% | -$282K |
|
2518
MMTec
MTC
$391M
| $41.4K | ﹤0.01% |
+4,313
| New | +$43.6K |
|
|
SRTA
2519
Strata Critical Medical Inc
SRTA
$440M
| $41K | ﹤0.01% |
+12,133
| New | +$49.5K |
|
|
GOEV
2520
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $39.4K | ﹤0.01% |
132
-20
| -13% | -$8.47K |
|
2521
CALL
Verizon
VZ
$193B
| $38.9K | ﹤0.01% |
1,000
| – | – |
|
|
FRBK
2522
DELISTED
Republic First Bancorp Inc
FRBK
| $38.4K | ﹤0.01% |
28,254
-173,776
| -86% | -$341K |
|
2523
NextNav
NN
$1.83B
| $38K | ﹤0.01% |
+18,700
| New | +$50.1K |
|
2524
Nektar Therapeutics
NKTR
$2.41B
| $37.7K | ﹤0.01% |
+3,593
| New | +$109K |
|
2525
Ring Energy
REI
$315M
| $36.6K | ﹤0.01% |
19,241
-10,794
| -36% | -$23.3K |
|
Similar funds
Marshall Wace's Q1 2023 Portfolio in Review
As of Q1 2023, Marshall Wace held 3,576 positions worth $47.1B, up 5.9% from $44.5B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Marshall Wace's Q1 2023 filing shows 705 new, 706 increased, 825 reduced and 988 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 541,764 shares worth $131M. The largest sale was Cigna, an estimated $312M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Technology and Consumer Discretionary.
- Marshall Wace's largest Q1 2023 buy was Madrigal Pharmaceuticals: 541,764 shares worth $131M.
- Marshall Wace added most to Walmart Inc in Q1 2023, an estimated $417M increase.
- Marshall Wace's biggest Q1 2023 reduction was Cigna, cutting an estimated $312M.
- Marshall Wace fully exited Merck in Q1 2023, selling an estimated $115M.
- Marshall Wace's ten largest holdings make up 14% of its $47.1B portfolio in Q1 2023.
- Marshall Wace opened 705 new positions and closed 988 in Q1 2023.
- Marshall Wace's portfolio value rose 5.9% quarter-over-quarter to $47.1B.
Based on Marshall Wace's 13F filing for Q1 2023, filed 15 May 2023.